Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIOMARIN PHARMACEUTICAL INC (BMRN)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Dec-31-20 | Sep-30-20 |
| | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 724.5 | 619.8 | 605.4 | 587.3 | 617.1 | 641.5 | 649.2 | 1,015.7 |
| Short-term investments | 567.0 | 489.9 | 450.8 | 426.6 | 462.3 | 481.9 | 416.2 | 490.0 |
| Accounts receivable, net | 461.3 | 466.5 | 430.1 | 373.4 | 374.9 | 424.4 | 448.4 | 411.7 |
| Inventories | 894.1 | 802.3 | 786.4 | 776.7 | 749.4 | 711.0 | 698.5 | 700.8 |
| Other current assets | 104.5 | 139.0 | 121.3 | 110.4 | 107.8 | 99.0 | 129.9 | 120.7 |
| Total current assets | 2,751.5 | 2,517.6 | 2,394.0 | 2,274.4 | 2,311.6 | 2,357.8 | 2,342.2 | 2,739.0 |
| Property, plant, and equipment, net | 1,073.4 | 1,049.5 | 1,039.5 | 1,035.5 | 1,024.8 | 1,026.6 | 1,032.5 | 1,015.1 |
| Intangibles | 338.6 | 369.4 | 374.3 | 388.7 | 388.5 | 394.3 | 417.3 | 427.2 |
| Goodwill | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 |
| Long-term investments | 333.8 | 412.5 | 462.8 | 507.8 | 466.6 | 350.2 | 285.5 | 265.1 |
| Other fixed assets | 176.2 | 151.8 | 149.2 | 152.1 | 144.7 | 141.7 | 142.2 | 119.0 |
| Total assets | 6,375.1 | 6,145.8 | 6,062.7 | 6,004.8 | 5,977.5 | 5,898.5 | 5,848.0 | 6,158.1 |
| |
| Accrued expenses | 223.5 | 157.9 | 191.9 | 252.7 | 206.3 | 161.9 | 165.0 | 137.4 |
| Current portion of long-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 374.3 |
| Current portion of long-term debt | | | | | | | | 374.3 |
| Other current liabilities | 365.4 | 306.8 | 298.5 | 293.8 | 308.6 | 281.5 | 327.5 | 343.0 |
| Total current liabilities | 588.9 | 464.7 | 490.4 | 546.5 | 514.9 | 443.3 | 492.5 | 854.7 |
| Long-term debt | 1,083.0 | 1,081.0 | 1,080.1 | 1,079.1 | 1,078.1 | 1,077.1 | 1,075.1 | 1,074.2 |
| Other liabilities | 100.0 | 95.3 | 100.9 | 113.5 | 118.3 | 136.5 | 174.3 | 175.3 |
| Total liabilities | 1,771.9 | 1,641.0 | 1,671.4 | 1,739.1 | 1,711.3 | 1,656.9 | 1,742.0 | 2,104.2 |
| |
| Shareholders' equity [+] | 4,603.2 | 4,504.8 | 4,391.3 | 4,265.7 | 4,266.1 | 4,241.6 | 4,106.0 | 4,053.9 |
| Paid-in capital | 5,404.9 | 5,272.7 | 5,206.3 | 5,191.5 | 5,133.7 | 5,083.8 | 4,993.4 | 4,937.8 |
| Retained earnings | -789.2 | -777.2 | -804.9 | -930.8 | -867.8 | -831.3 | -861.6 | -883.7 |
| Tangible shareholders' equity | 4,068.4 | 3,939.2 | 3,820.9 | 3,680.8 | 3,681.5 | 3,651.1 | 3,492.5 | 3,430.5 |
|